InvestorsHub Logo
Followers 2543
Posts 250731
Boards Moderated 34
Alias Born 05/06/2014

Re: Ster345 post# 415

Monday, 09/25/2017 1:06:18 PM

Monday, September 25, 2017 1:06:18 PM

Post# of 561
$CBIO https://www.streetinsider.com/Corporate+News/Catalyst+Biosciences+%28CBIO%29+Completes+First+Subcutaneous+Dosing+Cohort+in+Ongoing+Hemophilia+B+Clinical+Trial/13323360.html
Catalyst Biosciences (CBIO) Completes First Subcutaneous Dosing Cohort in Ongoing Hemophilia B Clinical Trial
StreetInsider.com - 4h ago


Catalyst Biosciences, Inc. (Nasdaq: CBIO), today announced that its collaborator ISU Abxis has completed dosing of the first subcutaneous cohort (N = 3, the second of up to five patient cohorts) in an ongoing Phase 1/2 proof-of-concept clinical trial ...

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CBIO News